Acute stress increases interstitial fluid amyloid-β via corticotropin-releasing factor and neuronal activity

被引:171
作者
Kang, Jae-Eun
Cirrito, John R.
Dong, Hongxin
Csernansky, John G.
Holtzman, David M.
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA
[6] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA
关键词
Alzheimer's disease; synaptic activity; environmental stress; microdialysis; transgenic;
D O I
10.1073/pnas.0700148104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aggregation of the amyloid-beta (A beta) peptide in the extracellular space of the brain is critical in the pathogenesis of Alzheimer's disease. A beta is produced by neurons and released into the brain interstitial fluid (ISF), a process regulated by synaptic activity. To determine whether behavioral stressors can regulate ISF A beta levels, we assessed the effects of chronic and acute stress paradigms in amyloid precursor protein transgenic mice. Isolation stress over 3 months increased A beta levels by 84%. Similarly, acute restraint stress increased A beta levels over hours. Exogenous corticotropin-releasing factor (CRF) but not corticosterone mimicked the effects of acute restraint stress. Inhibition of endogenous CRF receptors or neuronal activity blocked the effects of acute stress on A beta. Thus, behavioral stressors can rapidly increase ISF A beta through neuronal activity in a CRF-dependent manner, and the results suggest a mechanism by which behavioral stress may affect Alzheimer's disease pathogenesis.
引用
收藏
页码:10673 / 10678
页数:6
相关论文
共 43 条
  • [11] 2-8
  • [12] Cellular and molecular mechanisms of hippocampal activation by acute stress are age-dependent
    Chen, Y.
    Fenoglio, K. A.
    Dube, C. M.
    Grigoriadis, D. E.
    Baram, T. Z.
    [J]. MOLECULAR PSYCHIATRY, 2006, 11 (11) : 992 - 1002
  • [13] Hippocampal corticotropin releasing hormone: Pre- and postsynaptic location and release by stress
    Chen, Y
    Brunson, KL
    Adelmann, G
    Bender, RA
    Frotscher, M
    Baram, TZ
    [J]. NEUROSCIENCE, 2004, 126 (03) : 533 - 540
  • [14] Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
    Cirrito, JR
    Yamada, KA
    Finn, MB
    Sloviter, RS
    Bales, KR
    May, PC
    Schoepp, DD
    Paul, SM
    Mennerick, S
    Holtzman, DM
    [J]. NEURON, 2005, 48 (06) : 913 - 922
  • [15] Cirrito JR, 2003, J NEUROSCI, V23, P8844
  • [16] Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia
    Csernansky, John G.
    Dong, Hongxin
    Fagan, Anne M.
    Wang, Lei
    Xiong, Chengjie
    Holtzman, David M.
    Morris, John C.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (12) : 2164 - 2169
  • [17] RECIPROCAL CHANGES IN CORTICOTROPIN-RELEASING FACTOR (CRF)-LIKE IMMUNOREACTIVITY AND CRF RECEPTORS IN CEREBRAL-CORTEX OF ALZHEIMERS-DISEASE
    DESOUZA, EB
    WHITEHOUSE, PJ
    KUHAR, MJ
    PRICE, DL
    VALE, WW
    [J]. NATURE, 1986, 319 (6054) : 593 - 595
  • [18] Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress
    Dong, H
    Goico, B
    Martin, M
    Csernansky, CA
    Bertchume, A
    Csernansky, JG
    [J]. NEUROSCIENCE, 2004, 127 (03) : 601 - 609
  • [19] Disease modifying therapy for AD?
    Golde, Todd E.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2006, 99 (03) : 689 - 707
  • [20] Glucocorticoids increase amyloid-β and tau pathology in a mouse model of Alzheimer's disease
    Green, Kim N.
    Billings, Lauren M.
    Roozendaal, Benno
    McGaugh, James L.
    LaFerla, Frank M.
    [J]. JOURNAL OF NEUROSCIENCE, 2006, 26 (35) : 9047 - 9056